CytRx said this week that it has named Benjamin Levin as the company’s new general counsel, vice president of legal affairs, and corporate secretary.
According to CytRx, Levin has spent the last four years at the firm of O’Melveny & Myers as a transactional lawyer. He graduated from Stanford Law School, and holds an SB in economics from the Massachusetts Institute of Technology.
CytRx also said this week that Marvin Selter has been named vice chairman of the company’s board of directors. Selter, said the company, has been on CytRx’s board since October 2003 and currently serves as chairman of CytRx’s audit committee.
Selter is also president of CMS, a management consulting firm, said CytRx. He also serves on the boards of Olive View-UCLA Medical Center Foundation, San Fernando Economic Alliance, Valley Economic Development Center, and the California State University- Northridge Economic Development Center, said CytRx.
Congressman James Greenwood (R) was named the next president of the Biotechnology Industry Organization last week.
Greenwood has represented the Eighth District of Pennsylvania in the US House of Representatives since 1993, and serves on the Energy and Commerce, and Education and the Workforce Committees. He previously served in the Pennsylvania House and Senate.
Since 2001, Greenwood has served as chairman of the Energy and Commerce Subcommittee on Oversight and Investigations. He will be replacing Carl Feldbaum, who has headed BIO since its establishment in July 1993, and announced plans for his retirement in February.
Francis Crick, who with James Watson discovered and elucidated the double-helix structure of DNA, has passed away at age 88, according to the Salk Institute for Biological Studies, where Crick was a researcher and formerly served as president.
Crick, who was suffering from colon cancer, died Wednesday at Thornton Hospital of the University of California, San Diego.
“Francis Crick will be remembered as one of the most brilliant and influential scientists of all time,” Richard Murphy, the Salk Institute’s president and chief executive officer, said in a statement. “He will be missed as a gentleman, a role model, and a person who has contributed so much to our understanding of biology and the health of mankind. For those of us privileged to know him at Salk, he will also be remembered as a dear friend. “